WeVote
Log In

Bill

Bill

SB 1504

Relating to the administration of epinephrine.

2026 Regular Session

SB 1504 expands epinephrine administration authority in Oregon, likely authorizing lay responders and public facilities to stock and use auto-injectors for emergency anaphylaxis treatment.

Governor signed.
0
WeVote Research Nonpartisan
Bill Summary · SB 1504

Legislative bill overview

SB 1504 modifies Oregon law governing the administration and distribution of epinephrine, likely expanding access to auto-injectors (EpiPens) in schools, public spaces, or by lay responders. The bill has completed the legislative process and received gubernatorial approval in March 2026.

Why is this important

Epinephrine auto-injectors are critical emergency medications for severe allergic reactions (anaphylaxis), which can be fatal within minutes. Expanding access and clarifying legal protections for those administering epinephrine can improve survival outcomes in life-threatening situations, particularly in settings like schools where trained medical personnel may be unavailable.

Potential points of contention

  • Standing orders vs. prescriptions: Legislation expanding epinephrine access typically involves allowing non-prescribed auto-injectors in public spaces, which some argue bypasses traditional pharmaceutical oversight while others see as necessary emergency preparedness
  • Liability and training requirements: Questions about whether lay administrators need formal training, certification, or Good Samaritan protections to administer epinephrine without legal consequences
  • Cost and funding: Who pays for stocking epinephrine in public facilities, and whether costs should fall on schools, municipalities, or private entities

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.